Drugs.com - FDA MedWatch Alerts

FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain

Audience: Consumers April 14, 2025 -- FDA was notified by Novo Nordisk on April 3, 2025, that several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg were in the U.S. drug supply chain. The counterfeit products were distributed...

Apr 15, 2025 - 05:50
 0
FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain
Audience: Consumers April 14, 2025 -- FDA was notified by Novo Nordisk on April 3, 2025, that several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg were in the U.S. drug supply chain. The counterfeit products were distributed...
Read More

Tags:

Previous Article

Novo Nordisk Warns Consumers About Counterfeit Ozempic (semaglutide) Injection 1...

Next Article

Exclusive: Jean Paul Gaultier Names Duran Lantink Creative Director

Related Posts

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination

Bionpharma Inc. Issues Voluntary Nationwide Recall of A...

Feb 9, 2025  0

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMa...

Feb 9, 2025  0

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Provepharm Inc. Issues Recall of One Lot of Phenylephri...

Feb 9, 2025  0